Incyte to Present at Upcoming Investor Conference

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte (Nasdaq: INCY) announced today that it will present at Citi’s 2024 Global Healthcare Conference on Tuesday, December 3, 2024 at 3:15 p.m. in Miami.

The presentation will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241114668714/en/

Media
[email protected]

Investors
[email protected]

Source: Incyte

You May Also Be Interested In

• Incyte (INCY) PT Raised to $113 at UBS
• Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: June Shipment, Sales and Deliveries Hit 242 units, Company Plans to Raise Yearly Shipment Target to 2,000 Units and Becomes
• Alabama Insurance Broker Offers Quotes From 7+ Carriers